Laumas Sandeep bought UNCY
May 14, 2026 · Form 4 insider transaction
Laumas Sandeep bought 42,100 shares of Unicycive Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,100
Price
$0.00
Total value
N/A
InsiderLaumas Sandeep
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMay 14, 2026
Filing dateMay 18, 2026
Shares owned after126,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents grant of restricted stock units (the "Annual RSU Award") payable solely in common stock of the Issuer. The shares subject to the Annual RSU Award shall vest one year after date of grant, subject to the Reporting Person's continued service with the Issuer.